Skip to content
Neuro-ophthalmology

Acquired Oculomotor Nerve Palsy

1. What is Acquired Oculomotor Nerve Palsy?

Section titled “1. What is Acquired Oculomotor Nerve Palsy?”

Acquired oculomotor nerve palsy is an eye movement disorder caused by damage to the third cranial nerve (oculomotor nerve). The oculomotor nerve innervates the following muscles:

  • Somatic extraocular muscles: superior rectus, inferior rectus, medial rectus, inferior oblique, and levator palpebrae superioris
  • Autonomic nerves: sphincter pupillae and ciliary muscles (parasympathetic fibers)

These impairments result in a combination of ptosis, restricted eye movement, pupillary dilation, and accommodation disorder. Palsy is classified as complete or partial (superior branch or inferior branch palsy). Oculomotor nerve palsy is the second most common cranial nerve palsy.

The frequency of causes in adults is as follows:

CauseAdults (approximate)Children (approximate)
Ischemic (diabetes, hypertension, etc.)Approximately 20%Rare
AneurysmApproximately 20%Approximately 7%
TumorApproximately 15%Approximately 10%
TraumaApproximately 10%Approximately 13–23%
CongenitalApproximately 43–47%

In daily clinical practice, vascular causes (ischemia due to diabetes, hypertension, or arteriosclerosis) are the most common. In adults, paralytic strabismus often resolves spontaneously when caused by circulatory disorders or trauma, but in children, except for infectious causes, brain tumors account for the majority, so it must be treated as an emergency. In children, congenital causes are most common, followed by trauma.

Q Is acquired oculomotor nerve palsy a rare disease?
A

It is the second most common cranial nerve palsy and is encountered in daily clinical practice. In adults, ischemic causes are most common, and special attention is needed in elderly patients, diabetics, and hypertensive patients.

  • Diplopia: One of the most common ocular symptoms. Often presents with sudden onset of double vision.
  • Ptosis: Accounts for about 70% of initial symptoms. Complete paralysis of the levator palpebrae superioris results in complete closure of the palpebral fissure.
  • Eye pain and headache: May occur as irritative symptoms in the first division of the trigeminal nerve. Aneurysms may be accompanied by particularly severe headache.
  • General neurological symptoms: Depending on the lesion site, hemiparesis, involuntary movements, or impaired consciousness may be present.

Findings differ between complete and partial palsy.

Complete Palsy

Eye position: Exotropia with mild hypotropia in primary gaze.

Eye movement: Limited adduction (does not cross midline), limited elevation, and limited depression. If the trochlear nerve is intact, intorsion is observed during depression.

Eyelid: Complete ptosis.

Pupil: Dilated, with absent direct and consensual light reflexes.

Partial Palsy

Superior branch palsy: Ptosis plus superior rectus palsy (limited elevation). In cavernous sinus aneurysms, superior branch palsy is more common than inferior branch palsy.

Inferior branch palsy: Presents with a combination of deficits in the pupillary fibers, inferior rectus, inferior oblique, and medial rectus muscles.

Aberrant regeneration: Common after trauma or compressive lesions. Seen in 61–93% of congenital oculomotor nerve palsy cases.

Q Why is oculomotor nerve palsy with a dilated pupil (mydriasis) highly urgent?
A

The parasympathetic fibers of the oculomotor nerve (controlling the pupillary sphincter) run in the most superficial and dorsomedial part of the nerve, making them vulnerable to compression. Mydriasis suggests external compression by a posterior communicating artery aneurysm, which can rupture and cause fatal subarachnoid hemorrhage. See also “Causes and Risk Factors”.

  • Vascular causes (most common in daily practice): Ischemia due to diabetes, hypertension, or arteriosclerosis. Sudden onset, often noticed as double vision upon waking. Common in the elderly. Usually not accompanied by mydriasis.
  • Posterior communicating artery aneurysm (IC-PC aneurysm): The most important compressive lesion. Often presents with pupillary dilation as the initial symptom. Rupture is life-threatening and constitutes a medical emergency.
  • Uncal herniation: Compression of the oculomotor nerve due to transtentorial herniation from increased intracranial pressure. The most common cause is intracranial hemorrhage.
  • Tumor: Lateral extension of pituitary tumor, meningioma, etc. Accounts for about 15% in adults.
  • Trauma: Accounts for about 10% in adults. Often associated with severe head injury. Aberrant regeneration is common after trauma.
  • Inflammatory (Tolosa-Hunt syndrome): Painful ophthalmoplegia due to idiopathic granulomatous inflammation. Responds well to steroids.
  • Diabetic neuropathy: Arteriosclerotic occlusion of nutrient vessels within the cavernous sinus. Usually does not involve mydriasis, but not always normal. Good prognosis with recovery within a few months.
  • Others: Sinus fungal infection, herpes zoster, giant cell arteritis, meningitis, encephalitis, collagen vascular disease vasculitis, leukemia, Hodgkin lymphoma, complications after neurosurgery, etc.

Main risk factors: diabetes, hypertension, vasculitis, infection, trauma, tumor, aneurysm.

Q What are the characteristics of diabetic oculomotor nerve palsy?
A

Oculomotor nerve palsy due to diabetic neuropathy is caused by atherosclerotic occlusion of the nutrient vessels within the cavernous sinus. Ischemia affects the nerve interior, but because the pupillary fibers have abundant collateral circulation, it is usually not accompanied by mydriasis. The prognosis is good, with recovery often occurring within a few months, and treatment of diabetes is the top priority.

Diagnosis is based on clinical findings, but various tests are essential to identify the cause.

Medical History and Ophthalmic Examination

Section titled “Medical History and Ophthalmic Examination”
  • Medical history: Onset pattern (sudden or gradual), presence of eye pain or headache, history of diabetes or hypertension, diurnal variation of symptoms (important for differentiating from myasthenia gravis)
  • Ocular motility assessment: Check for limitations in each direction of gaze and conjugate eye movements
  • Levator palpebrae superioris function: Evaluate whether ptosis is complete or partial
  • Pupillary light reflex and accommodation reflex: Check for absence of direct and consensual light reflexes
  • Slit-lamp examination: Check for intorsion of the eye on adduction and depression to differentiate trochlear nerve palsy

A comparison of major imaging modalities is shown below.

ModalityFeatures and Uses
MRI (SPGR method)High resolution with thin slices (2–3 mm). Clearly depicts compression by IC-PC aneurysm.
MRANoninvasive cerebral artery depiction. Simplest and most diagnostically valuable for detecting IC-PC aneurysm.
CTA (3D-CT angiography)Sensitivity 90% for aneurysms ≥3 mm in diameter. Can be first-line along with MRA.
DSA (digital subtraction angiography)Gold standard. Invasive but most accurate.

MRI (T1-weighted, T2-weighted, fat-suppressed, diffusion-weighted, and gadolinium-enhanced) is the basic imaging modality and is more useful than CT.

  • Blood tests: CBC, ESR, CRP, comprehensive metabolic panel (CMP). Add antinuclear antibody, C-ANCA, P-ANCA, ACE, β-D-glucan, etc., as needed.
  • Cerebrospinal fluid analysis: Performed when cavernous sinus or skull base lesions are suspected.
  • Pathological diagnosis (biopsy): May be necessary for definitive diagnosis.
Q How to differentiate oculomotor nerve palsy from myasthenia gravis?
A

Myasthenia gravis is characterized by diurnal variation (worsening in the evening), and the ice test (sensitivity 80–92%) or Tensilon test is useful for differentiation. Anti-AChR antibodies have a positivity rate of 50% or less in ocular myasthenia, so a negative result does not rule it out. It is also important to exclude organic lesions of the oculomotor nerve and orbit using MRI/CT.

Treatment of the underlying disease is the highest priority. The treatment strategy according to the cause is shown below.

Ischemic

Natural course: Improvement often begins within 4 weeks of onset, and complete recovery is expected within 12 weeks. It has been reported that 81.8% of microvascular third nerve palsies recover completely within 3 months and 90.9% within 12 months (Galtrey 2014, PMID: 27928323).

Pharmacotherapy: Oral vitamin B complex and circulation-improving drugs are administered to promote recovery.

Aneurysm

Emergency response: Urgent neurosurgical treatment (clipping, coil embolization, etc.) is performed.

Same-day imaging and emergency referral to a specialist are required.

Inflammatory (Tolosa-Hunt)

Steroid therapy: Prednisolone 50–60 mg/day is administered for the first 3 days. Orbital pain often improves dramatically.

Caution: Early dose reduction may cause relapse; taper gradually as appropriate.

Traumatic

Observation: Recovery is relatively difficult. If no improvement after 6 months, surgical treatment is considered.

  • Diabetic: Prioritize treatment of diabetes. Prognosis is good, and recovery often occurs within a few months.
  • Tumor/uncinate hernia: Perform surgical or medical treatment of the underlying disease.

Management of Residual Defects (Symptomatic Treatment)

Section titled “Management of Residual Defects (Symptomatic Treatment)”
  • Prism glasses: Consider after 6 months when symptoms have stabilized.
  • Botulinum toxin: Chemical denervation by injection into the antagonist muscle temporarily reduces diplopia.
  • Strabismus surgery: Main purpose is to correct eye position in primary gaze and reading position. In complete paralysis, combine supra-maximal recession, resection, and suturing to the lateral orbital wall periosteum of the lateral rectus, nasal transposition of the superior oblique toward the medial rectus insertion, and maximal shortening of the medial rectus. If aberrant regeneration is present, avoid surgery on muscles with secondary innervation.
  • Ptosis surgery: If Bell’s phenomenon is significantly impaired, attention to the risk of exposure keratopathy is necessary.
Q How long does it take for ischemic oculomotor nerve palsy to recover?
A

In most cases, improvement begins within 4 weeks of onset, and complete recovery is expected within 12 weeks (about 3 months). Vitamin B complex and circulation-improving drugs are administered to promote recovery. If no improvement is seen after more than 6 months, other causes such as trauma or management of residual deficits (strabismus surgery, prism glasses) should be considered.

6. Pathophysiology and Detailed Mechanism of Onset

Section titled “6. Pathophysiology and Detailed Mechanism of Onset”

The oculomotor nucleus is located in the midbrain tegmentum and has a complex nuclear structure. The innervation of each subnucleus is as follows.

  • Medial rectus, inferior rectus, and inferior oblique nucleus: ipsilateral innervation
  • Superior rectus nucleus: contralateral innervation (crossing site unknown)
  • Levator palpebrae superioris nucleus (caudal central nucleus): Single nucleus with bilateral innervation
  • Autonomic nucleus (including Edinger-Westphal nucleus): Located rostrally in the nuclear group, ipsilateral innervation

The intranuclear fiber arrangement is rostral-caudal: the most rostral part contains parasympathetic fibers, followed by inferior rectus and inferior oblique, and the most caudal part contains levator palpebrae superioris and superior rectus. Mediolaterally, superior rectus and inferior oblique are lateral, while pupillary fibers and inferior rectus are medial.

Peripherally, pupillary fibers run in the dorsomedial (superonasal) aspect of the oculomotor nerve’s outermost layer, making them vulnerable to compression but relatively resistant to ischemia (due to rich collateral circulation). This anatomical basis underlies the clinical rule: compressive lesions cause mydriasis, while ischemic lesions spare the pupil.

Nuclear Lesion

Features: Usually causes bilateral deficits.

Unilateral nuclear palsy presents with ipsilateral oculomotor nerve palsy, moderate bilateral ptosis, and contralateral superior rectus palsy.

Fascicular Lesion (Midbrain Syndrome)

Weber syndrome: Cerebral peduncle lesion. Ipsilateral oculomotor nerve palsy + contralateral hemiplegia.

Benedikt syndrome: Red nucleus lesion. Ipsilateral oculomotor nerve palsy + contralateral involuntary movements.

Claude syndrome: Red nucleus + superior cerebellar peduncle lesion. Ipsilateral oculomotor nerve palsy + contralateral ataxia and tremor.

Nothnagel syndrome: Superior cerebellar peduncle lesion. Ipsilateral oculomotor nerve palsy + cerebellar ataxia.

Subarachnoid Space, Cavernous Sinus, and Orbital Lesions

Section titled “Subarachnoid Space, Cavernous Sinus, and Orbital Lesions”
  • Subarachnoid space: Compression by posterior communicating artery aneurysm is most important. Compression due to uncal herniation also occurs. Since pupillary fibers run in the most superficial layer, mydriasis appears early.
  • Cavernous sinus: Combined palsy with other cranial nerves (IV, V1, VI) is common (cavernous sinus syndrome). After the oculomotor nerve divides into superior and inferior branches, branch palsy is more likely to occur.
  • Intraorbital: Accompanied by decreased visual acuity, ocular muscle paralysis, and proptosis. Branch palsy is likely to occur.

  • Fang C, Leavitt JA, Hodge DO, Holmes JM, Mohney BG, Chen JJ. Incidence and Etiologies of Acquired Third Nerve Palsy Using a Population-Based Method. JAMA Ophthalmol. 2017;135(1):23-28. PMID: 27893002.
  • Park UC, Kim SJ, Hwang JM, Yu YS. Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy. Eye (Lond). 2008;22(5):691-696. PMID: 17293794.
  • Yanovitch T, Buckley E. Diagnosis and management of third nerve palsy. Curr Opin Ophthalmol. 2007;18(5):373-378. PMID: 17700229.
  • Jacobson DM. Relative pupil-sparing third nerve palsy: etiology and clinical variables predictive of a mass. Neurology. 2001;56(6):797-798. PMID: 11274322.
  • Galtrey CM, Schon F, Nitkunan A. Microvascular Non-Arteritic Ocular Motor Nerve Palsies—What We Know and How Should We Treat? Neuroophthalmology. 2014;39(1):1-11. PMID: 27928323. PMCID: PMC5123092.
  • Dutta P, Anand K. Tolosa–Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues. J Curr Ophthalmol. 2021;33(2):104-111. PMID: 34409218. PMCID: PMC8365592.
  • Modi P, Singh J. Cranial Nerve III Palsy (Oculomotor Palsy). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. Bookshelf ID: NBK526112.
  • Adult Strabismus Preferred Practice Pattern(American Academy of Ophthalmology)

Copy the article text and paste it into your preferred AI assistant.